BioSpace News Archive

Venturis Therapeutics, Inc. (“VT”) today announced it has applied for four provisional patents related to the treatment and/or prevention of virally induced illnesses related to the COVID-19 virus, as well as other viruses.

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today reported financial results for the first quarter of 2020 and associated Company developments

The U.S. Food and Drug Administration continued to take action in the ongoing response effort to the COVID-19 pandemic

AbbVie Inc. (NYSE:ABBV) (“AbbVie”) announced today the extension of the expiration date of the offers to exchange (each, an “Exchange Offer” and, collectively, the “Exchange Offers”) any and all outstanding notes of certain series issued by Allergan Finance, LLC (“Allergan Finance”), Allergan, Inc. (“Allergan Inc”), Allergan Sales, LLC (“Allergan Sales”) and Allergan Funding SCS

Nordic Nanovector ASA is pleased to announce the grant of a US patent covering the use of Betalutin® for sensitising CD37-positive B-cell cancer cells before treatment with CD20 immunotherapy.

Objective responses seen in approximately 29% of patients with locally advanced basal cell carcinoma (BCC)

On May 12th, 2020, at 08:00 am, Moberg Pharma AB will present its Interim report for July 2019 - March 2020.

Unique transdermal delivery technology and medicines for rare diseases combine to deliver significant quality-of-life benefits for patients

Medivir’s patent applications for MIV-818, covering both substance requirements for MIV-818 and its use for liver cancer treatment, were approved by the patent authorities in both the EU and Japan.

A new interdisciplinary hub to analyse the impacts of the Coronavirus in area of healthcare, on society, the economy and finance, business and regards the legal system